Company profile

Enveda

Enveda is a drug discovery analytics company valued at $1.2 billion following its $150 million Series D, according to Pitchbook. Founded in 2019, the company has raised $520 million to date from investors including Lux Capital and True Ventures. Enveda uses advanced computational and biological data platforms to accelerate molecule discovery and improve drug development outcomes. With strong backing and rapid funding momentum, the company is positioned for continued growth in the biotech and pharmaceutical innovation space.

Back to profiles

Quick facts

Total funding: $520 million
Founded: 2019

Notable investors

Lux Capital
True Ventures

Reach buyers like Enveda on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Enveda
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Enveda.

The 14-day trial ships every feature, no card required.

Start free →